Market Pulse
Stocks kicked off the holiday stretch with a solid rally as traders ratcheted up bets on sooner-than-expected rate cuts. Bond yields eased, fueling that risk-on sentiment. Gold and silver didn’t just climb—they blasted through prior highs on a cocktail of global risk aversion and Fed-watching. This backdrop sets an upbeat tone for the final trading days of the year.
Key Movers
Novo Nordisk stole headlines after the FDA cleared the first-ever oral Wegovy weight-loss pill (Independent.ie). Agios captured approval for AQVESME™ to treat anemia in thalassemia patients (GlobeNewswire). Edwards Lifesciences earned the nod for its SAPIEN M3 mitral valve system (Thefly.com). MannKind also won sNDA clearance for its FUROSCIX on-body infusor (Thefly.com).
Macro & Politics
New Delhi is prepping a fresh stake sale in IDBI Bank come mid-January (Ndtvprofit.com), a familiar move from budget-driven governments. Oyo dusted off its IPO filing after over a crore of WhatsApp bans, reigniting the free-market vs. red-tape debate (The Times of India). Meanwhile, Washington’s fiscal grandstanding could jostle risk appetite.
What’s Next
Eyes are on Fed minutes and incoming GDP chatter—plus any political maneuvers on fiscal policy that could flip the script on market sentiment.
Unfiltered Market Commentary
Everyone’s missing how these blockbuster pharma approvals are masking a deeper liquidity trap on the horizon. Sure, FDA clears the Wegovy pill and AQVESME™ makes headlines, but Fed minutes next week could expose how thin this rally really is if you look under the hood—liquidity’s thinner than hell. Traders are piling into stocks like there’s no tomorrow, ignoring the jittery bond market beneath the surface.
Linking biotech breakthroughs to record-setting precious metals rallies sounds weird, but it makes sense: fear and greed are two sides of the same coin. On one hand, investors pour cash into growth stories like Novo Nordisk’s Wegovy pill (Independent.ie) and Edwards Lifesciences’ SAPIEN M3 (Thefly.com). On the other, they’re chasing gold and silver highs (Financial Post) as a hedge against policy missteps. This push-pull dynamic underscores a market that’s desperate for a clear direction—and neither side looks wholly convincing.
If you’re looking for a trade, bet on volatility here—set tight stops on your pharma longs and consider adding a small gold allocation as insurance. Don’t be the guy who waits for the perfect setup; position yourself now before lawmakers or the Fed blow out the engines. Remember, markets reward decisiveness, not indecision.
📈 Breaking Financial News
Edwards Lifesciences receives FDA approval for SAPIEN M3 mitral valve system
See the rest of the story here.
thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual investors, professional money managers, active traders, and corpor…
MannKind announes FDA approval of sNDA for FUROSCIX On-body Infusor
See the rest of the story here.
thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual investors, professional money managers, active traders, and corpor…
Stock Market Today: Dow Falls Ahead Of GDP Data; Novo Soars On Weight Loss Pill (Live Coverage)
Stock Market Today: The Dow Jones index fell Tuesday ahead of Q3 GDP Data. Novo stock soared on FDA approval for a weight loss pill.
FDA clears pill version of Novo Nordisk's weight loss drug Wegovy
The US Food and Drug Administration’s (FDA) approval of an oral version of Novo Nordisk’s weight-loss drug Wegovy could potentially expand access to millions of patients and give the Danish company a much-needed fillip in the red-hot market.
Best Peptides for Muscle Growth: Prescription Sermorelin Access, Injectable vs. Dissolving Tablets, and Realistic Expectations
Analysis examines best peptides for muscle growth as ReadyRx lists prescription sermorelin in injectable and dissolving formats before 2026….
Why Are 21 Billionaires Moving Their Money ASAP?
Under the surface of the U.S. financial system… One of the biggest stock market events in 25 years is rapidly unfolding… The economist who predicted the 2008 Financial Crisis says it will be: “The Biggest Crash of Our Lifetime.” Soon your favorite tech stocks like Nvidia, Apple, Microsoft, Google , and hundreds more could come crashing down…
🔍 Market Analysis & Insights
U.S. FDA Approves Agios’ AQVESME™ (mitapivat) for the Treatment of Anemia in Adults with Alpha- or Beta-Thalassemia
Agios today announced that the U.S. FDA has approved AQVESME™ (mitapivat), an oral pyruvate kinase (PK) activator, for thalassemia…
Gold and silver rise to records on rate-cut bets, global risks
Gold and silver rallied to fresh all-time highs on escalating geopolitical tensions and prospects for more United States rate cuts. Read now
The First Big Lie of Vaccinology
As discussed in the introductory essay in this series, standard doctrine surrounding vaccines – pertaining to clinical trials, licensing, marketing, and vaccination schedules – is largely a pseudoscientific façade, constructed on a shaky foundation of falseho…
Wegovy Pill Becomes First Oral GLP-1 Weight-loss Drug Approved in U.S.
A pill version of the popular GLP-1 weight-loss drug Wegovy has been green-lit for use in the U.S. Here’s what that means for health care
Single Injection Transforms the Immune System Into a Cancer-Killing Machine
The treatment reprograms T cells to hunt down a patient's cancer. The approach could speed treatment and cut costs, but needs more study.
The post Single Injection Transforms the Immune System Into a Cancer-Killing Machine appeared first on SingularityHub.
30 Million Ounces of Gold Just Moved to the U.S.
And It's Not a Coincidence… A historic gold transfer is underway – and according to 20-year gold analyst Garrett Goggin, it's a clear signal the global monetary system is about to change. Central Banks are already buying at record pace. But Goggin says four tiny miners are positioned for the biggest upside – with 100X potential as this “Golden Anomaly” unfolds. Click here to get all four picks before the window closes.
💰 Investment Opportunities
Revive Rx LLC dba Revive Rx Pharmacy – 709509 – 09/22/2025
Compounding Pharmacy/Adulterated Drug Products
IDBI Bank Stake Sale: Govt Set To Invite Financial Bids In Mid-January, Sources Say
The successful bidder for IDBI Bank's stake is likely to be announced by March-end, sources said.
Beyond 1 crore WhatsApp bans; Oyo reattempts path to IPO
The government wants to know more about accounts banned by WhatsApp in India. This and more in today’s ETtech Top 5.
Profound Medical Corp. Closes $36 Million Registered Direct Offering; Expects to Complete Subsequent Private Placement On or Before December 30th
Financing included participation by healthcare-dedicated investors alongside existing shareholders TORONTO, Dec. 23, 2025 (GLOBE NEWSWIRE) — Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”) today announced the closing of its previou…
Profound Medical Corp. Closes $36 Million Registered Direct Offering; Expects to Complete Subsequent Private Placement On or Before December 30th
Financing included participation by healthcare-dedicated investors alongside existing shareholders Financing included participation by healthcare-dedicated investors alongside existing shareholders
Get out of “The World's Most Crowded Trade” Now Megacap tech stocks – like Nvidi
Yet, 78% of Wall Street fund managers believe an event is coming in September that could kill this trade and incite total “regime change” in the stock market. Watch Futurist Eric Fry's “Sell This, Buy That” broadcast for 7 alternative plays to help protect yourself from big tech's potential downturn. Get all the analysis, names and tickers FREE right here.